Results 161 to 170 of about 158,455 (262)

Long‐Term Impact of Prosthesis‐Patient Mismatch After Transcatheter Aortic Valve Replacement in Patients With Small Aortic Annuli

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Prosthesis‐patient mismatch (PPM) remains common following transcatheter aortic valve replacement (TAVR) and is associated with worse clinical outcomes. PPM is of particular concern in small aortic annuli (SAA). Aims To compare the incidence, predictors, and long‐term impact of PPM in SAA TAVR.
Itamar Loewenstein, Bar Gitter, Tamar Itach, Yaron Arbel, Jeremy Ben‐Shoshan, Maayan Konigstein, Ariel Finkelstein, Amir Halkin, Shmuel Banai, Arie Steinvil   +9 more
wiley   +1 more source

Cardioembolic sources and stroke prevention: a systematic review. [PDF]

Cardiovasc Ultrasound
Cozza E, Cito V, Giumbini G, Marsili G, Barletta M, Zannoni J, Mainardi C, Bedogni F, Tusa M.   +8 more
europepmc   +1 more source

Annular Ellipticity and Sizing Strategy in Transcatheter Aortic Valve Implantation: Independent or Combined Risk Patterns?

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Elliptical annular anatomy has been considered a risk factor for adverse outcomes after TAVI, particularly paravalvular leakage (PVL). Prosthesis oversizing is thought to improve sealing, but the interaction between annular shape and sizing strategy remains unclear.
Emre Polat, Lisa Müller, Lena Schemet, Sarah Friedrich Welz, Mohamed Amer, Evaldas Girdauskas, Tamer Owais   +6 more
wiley   +1 more source

Improvement of the left atrial systolic function after a surgical reduction of the high flow arteriovenous fistula. [PDF]

Front Med (Lausanne)
Lejsek V, Valerianova A, Michalickova K, Buryskova Salajova K, Slavikova M, Rybar M, Malik J.   +6 more
europepmc   +1 more source

Left Atrial Size and Function

Journal of the American College of Cardiology, 2014
openaire   +1 more source

Comprehensive Nursing Management of Anticoagulation and Heart Failure Surveillance in a Chinese Patient With Mirror‐Image Dextrocardia Post‐MitraClip Surgery: A First Case Report

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Mitral regurgitation (MR) is the valent type of valvular heart disease, caused by primary leaflet lesions or annular dilatation secondary to left ventricular dysfunction. It can lead to a series of complications such as volume overload, exacerbated pulmonary congestion, and heart failure, significantly impacting patient prognosis ...
Juelian Li, Chun Wu, Chao Shang, Yu Deng, Jinxia Zhang   +4 more
wiley   +1 more source

Left atrioventricular coupling in isolated pediatric mitral valve prolapse with preserved ejection fraction and moderate regurgitation. [PDF]

Sci Rep
Shokeir FA, Abdel Aziz AM, Karam R, Tawfik AI, Salem MA, Elboghdady A.   +5 more
europepmc   +1 more source

Causal Effects of Hydrophilic Bile Acids on Carfilzomib‐Related Cardiovascular Events in Multiple Myeloma: A Mendelian Randomization Study

Clinical Pharmacology &Therapeutics, EarlyView.
Carfilzomib is highly effective in the treatment of multiple myeloma, but it has been associated with cardiovascular adverse events that impact patient outcomes. Our prior global metabolomic analyses indicated an association between hydrophilic bile acids and carfilzomib‐cardiotoxicity risk, although a causal relationship remained to be determined ...
Samia Shabnaz, Eric Farber‐Eger, Marwa Tantawy, Neyousha Shahisavandi, Timothy J. Garrett, Samuel M. Rubinstein, Michael G. Fradley, Mohammed E. Alomar, Danny DeAvila, Kenneth H Shain, R. Frank Cornell, Daniel Lenihan, Qing Lu, Quinn S Wells, Rachid C. Baz, Yan Gong   +15 more
wiley   +1 more source

Association of type 2 diabetes with left atrioventricular coupling and myocardial deformation in hypertension: a 3.0 T cardiac magnetic resonance study. [PDF]

Front Cardiovasc Med
Li ZM, Li X, Guan XC, Chen YY, Ruan FQ, Long LL.   +5 more
europepmc   +1 more source

Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibition and Cancer Risk: Insights from a Large Propensity‐Matched Cohort Study

Clinical Pharmacology &Therapeutics, EarlyView.
Proprotein convertase subtilisin/kexin type 9 (PCSK9) monoclonal antibodies (mAbs) lower LDL cholesterol and may influence cancer through immunomodulatory pathways. However, their effect on human cancer incidence remains unknown. We conducted a retrospective, propensity score‐matched study (Clalit Health Services, Israel, 2010–2023) comparing PCSK9 ...
Inbar Nardi Agmon, Chen Gurevitz, Tzippy Shochat, Shiri Kushnir, Guy Witberg, Amos Levi, Dan Gilon, Ran Kornowski, Paaladinesh Thavendiranathan, Husam Abdel Qadir, Zaza Iakobishvili   +10 more
wiley   +1 more source